XML 39 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segment Information
 6 Months Ended
Apr. 30, 2022
Segment Reporting [Abstract]  
Business Segment Information Business Segment Information
The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below.
•CooperVision. Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues, with a broad collection of spherical, toric and multifocal contact lenses.
•CooperSurgical. Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.
The Company has 50% ownership in the new joint venture and accounts for this investment under the equity method of accounting. This joint venture is not considered material to the overall results of the Company and is grouped under CooperVision segment.
The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. The Company uses the same accounting policies to generate segment results as the Company does for consolidated results.
Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets.
Segment information:
Periods Ended April 30,Three MonthsSix Months
(In millions)2022202120222021
CooperVision net sales by category:
Toric lens$185.6 $172.8 $367.8 $335.1 
Multifocal lens66.4 58.0 132.2 115.7 
Single-use sphere lens161.1 144.5 328.1 290.5 
Non single-use sphere, other140.7 147.3 287.1 288.3 
Total CooperVision net sales$553.8 $522.6 $1,115.2 $1,029.6 
CooperSurgical net sales by category:
Office and surgical products$161.6 $112.6 $290.5 $216.1 
Fertility114.4 84.3 211.2 154.3 
CooperSurgical net sales276.0 196.9 501.7 370.4 
Total net sales$829.8 $719.5 $1,616.9 $1,400.0 
Operating income (loss):
CooperVision$135.4 $131.7 $262.8 $259.2 
CooperSurgical10.9 23.1 26.6 40.6 
Corporate(13.6)(11.6)(25.8)(23.2)
Total operating income132.7 143.2 263.6 276.6 
Interest expense10.8 6.1 17.4 12.5 
Other (income) expense, net (41.8)0.7 (39.4)(11.8)
Income before income taxes$163.7 $136.4 $285.6 $275.9 
(In millions)April 30, 2022October 31, 2021
Total identifiable assets:
CooperVision$6,825.6 $6,965.9 
CooperSurgical4,448.4 2,395.6 
Corporate504.0 244.7 
Total$11,778.0 $9,606.2 

Geographic information:
Periods Ended April 30,Three MonthsSix Months
(In millions)2022202120222021
Net sales to unaffiliated customers by country of domicile:
United States$418.9 $336.1 $784.2 $649.1 
Europe243.2 230.0 493.5 450.8 
Rest of world167.7 153.4 339.2 300.1 
Total$829.8 $719.5 $1,616.9 $1,400.0 
(In millions)April 30, 2022October 31, 2021
Net property, plant and equipment by country of domicile:
United States$786.9 $737.5 
Europe337.2 377.2 
Rest of world241.5 232.9 
Total$1,365.6 $1,347.6